Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 445,000 | 510,000 | 372,000 | 319,000 | 288,000 |
| Marketable Securities | N/A | N/A | 1,000 | 1,000 | 30,000 |
| Receivables | 272,000 | 243,000 | 272,000 | 287,000 | 271,000 |
| Inventories | 155,000 | 149,000 | 163,000 | 167,000 | 178,000 |
| Other current assets | 20,000 | 21,000 | 19,000 | 22,000 | 32,000 |
| TOTAL | $922,000 | $951,000 | $883,000 | $827,000 | $799,000 |
| Non-Current Assets | |||||
| PPE Net | 124,000 | 117,000 | 104,000 | 100,000 | 79,000 |
| Investments And Advances | 28,000 | 27,000 | 27,000 | 27,000 | 26,000 |
| Intangibles | 2,000 | 7,000 | 7,000 | 6,000 | 190,000 |
| Other Non-Current Assets | 342,000 | 349,000 | 355,000 | 355,000 | 370,000 |
| TOTAL | $496,000 | $500,000 | $493,000 | $488,000 | $665,000 |
| Total Assets | $1,416,000 | $1,452,000 | $1,375,000 | $1,316,000 | $1,464,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,000 | 18,000 | 18,000 | 18,000 | 3,000 |
| Accounts payable and accrued liabilities | 215,000 | 196,000 | 183,000 | 216,000 | 815,000 |
| Accrued Expenses | 719,000 | 814,000 | 780,000 | 661,000 | N/A |
| Other current liabilities | N/A | N/A | 3,000 | 11,000 | 124,000 |
| TOTAL | $965,000 | $1,056,000 | $1,005,000 | $924,000 | $962,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 304,000 | 308,000 | 311,000 | 315,000 | 235,000 |
| Other Non-Current Liabilities | 354,000 | 346,000 | 344,000 | 415,000 | 434,000 |
| TOTAL | $658,000 | $654,000 | $655,000 | $730,000 | $669,000 |
| Total Liabilities | $1,623,000 | $1,709,000 | $1,660,000 | $1,652,000 | $1,631,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 124,854 | 124,770 | 124,770 | N/A | N/A |
| Common Shares | 62,000 | 62,000 | 62,000 | 62,000 | 65,000 |
| Retained earnings | -346,000 | -388,000 | -406,000 | -443,000 | 1,070,000 |
| Other shareholders' equity | -32,000 | -32,000 | -34,000 | -46,000 | -1,315,000 |
| TOTAL | $-207,000 | $-257,000 | $-285,000 | $-337,000 | $-167,000 |
| Total Liabilities And Equity | $1,416,000 | $1,452,000 | $1,375,000 | $1,315,000 | $1,464,000 |